ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - melphalan - טבליה - melphalan 2 mg - melphalan - melphalan - for the palliative treatment of multiple myeloma and of non-epithelial carcinoma of the ovary.

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - chlorambucil - טבליה - chlorambucil 2 mg - chlorambucil

ישראל - עברית - Ministry of Health

padagis israel agencies ltd, israel - busulfan - טבליה - busulfan 2 mg - busulfan

ישראל - עברית - Ministry of Health

perrigo israel agencies ltd, israel - thioguanine - טבליה - thioguanine 40 mg - tioguanine - tioguanine - acute nonlymphocytic leukemia.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - talazoparib as tosylate - קפסולה קשיחה - talazoparib as tosylate 0.25 mg - talazoparib

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - talazoparib as tosylate - קפסולה קשיחה - talazoparib as tosylate 1 mg - talazoparib

ישראל - עברית - Ministry of Health

dexcel ltd, israel - caffeine; paracetamol - קפליות - paracetamol 500 mg; caffeine 50 mg - paracetamol - paracetamol - relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 250 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 500 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 750 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.